Page
%P
-
Article
Adjuvant Therapy After Liver Resection for Colorectal Cancer Metastasis: What is the Evidence?
Synchronous or metachronous liver metastases of colorectal origin (colorectal liver metastases, CLM), although being the expression of systemic disease, allow a curative approach for about 25% to 35% of patien...
-
Article
Should bevacizumab be continued beyond progression in colorectal cancer?
Medical therapy for advanced colorectal cancer has seen significant changes over the past decade. Most recently, molecular targeted agents such as antibodies against the epidermal growth factor receptor and th...